Virtus Biotech Clinical Trials ETF BBC
43.02 USD +2.29 (+5.62%)
At closeNov 6, 2026, 4:00 PM EST
43.02 0.00 0.00%
After hours · Nov 6, 4:00 PM ET
41.03 Day range 43.28
29.69 52-week range 56.03
- YTD
- +11.57%
- 1 year
- +43.26%
News
benzinga.com What's Going On With Alumis Stock Thursday? Alumis Inc. is drawing attention with a major share sale and bullish analyst forecasts. The firm aims to fund its immune disease pipeline.
benzinga.com Healthcare ETFs Trounce Tech, Grab Billions As Big Money Flees Bubble Fears Healthcare ETFs are raking in fresh inflows while tech bleeds, reflecting a defensive shift as investors grow wary of frothy valuations.
benzinga.com Vinay Prasad's Appointment To FDA's CBER Triggers Questions Over Future Of Cell And Gene Therapy Regulation FDA names Vinay Prasad to lead CBER, raising questions over biologics oversight and triggering biotech stock losses and analyst concerns.
benzinga.com ETFs Last Week: Funds Lead The Charge As Markets Stage A Return To Risk-On Investors ditched worries, boosting ETFs like VanEck SMH (+13%) on chip stock rally, Virtus BBC (+7%) on biotech hope, Simplify TESL (+31%) on Musk's focus, Invesco SPHB (+11.5%) on risk appetite,…
benzinga.com Why Is uniQure Stock Skyrocketing On Tuesday? uniQure stock surges after FDA agrees on an accelerated approval pathway for its Huntington's disease treatment, AMT-130.
benzinga.com Top 10 Trending Stocks On WallStreetBets As Of May 16, 2024 (Via Swaggy Stocks) BBAMCNVDAGMEGILWMTSMCITSLABBCAIData from https://swaggystocks.com/dashboard/wallstreetbets/ticker-sentiment